API Holdings Q3 FY26: Strong Shift from Cash Burn to Cost Discipline

API Holdings Q3 FY26: Strong Shift from Cash Burn to Cost Discipline

Business Model Overview

• API Holdings (PharmEasy) operates through three key verticals:
  • B2B (Ascent + Aknamed): Supplies medicines to retailers and hospitals, focusing on scale and supply chain efficiency
  • B2C (PharmEasy): Direct-to-consumer online pharmacy platform
  • Diagnostics (Thyrocare): Testing and diagnostics business, which is the most profitable segment

Overall Financial Performance (9M FY26)

• The company reported ~14.7% revenue growth compared to last year. 
• A major milestone: EBITDA at the group level turned positive, showing strong operational improvement. 
• Losses are reducing, indicating a clear shift from cash burn to financial discipline.

Segment-wise Performance

1. B2B (Ascent + Aknamed)

• Strong revenue growth with significant reduction in losses
• Improvement driven by better cost control and working capital management
• Working capital cycle improved from 54 days to 43 days 

2. B2C (PharmEasy)

• Growth remains stable
• Losses are narrowing with EBITDA margin improving from -5.6% to -3.5% 
• Indicates better unit economics and reduced discounting dependency

3. Hospitals (Aknamed)

• Slight decline in revenue
• However, sharp improvement in EBITDA due to aggressive cost-cutting 

4. Diagnostics (Thyrocare)

• Strongest performing segment
• Revenue grew by ~21% and EBITDA by ~39% 
• Acts as the profit engine of the group

Operational Improvements

• Company has tightened operations significantly:
  • Group working capital reduced from ~50 days to ~40 days 
  • B2C remains efficient at around 27 days 
• Indicates better cash flow management and faster cash conversion

Key Positives

• Clear shift to cost control and efficiency-led growth
• EBITDA turned positive, a major turnaround signal
• Diagnostics business providing strong and stable profitability
• Margins improving across B2B and B2C segments

Key Concerns / Overhang

• Despite operational improvement, net profitability is still negative
• Major issue:
  • High finance cost (~₹340 Cr) continues to drag profits 
• Debt burden remains high:
  • Around ₹1,080 Cr still outstanding 
• One-time costs (like wage code implementation) also impacted results

Strategic Shift

• Company is no longer chasing aggressive growth
• Focus areas now:
  • Cost efficiency
  • Improved unit economics
  • Better cash flow discipline

Overall Conclusion

• API Holdings is undergoing a clear operational turnaround
• Business structure is stabilizing:
  • Diagnostics drives profits
  • B2B is improving
  • B2C is moving towards breakeven
• However, debt reduction is the key trigger ahead
• Until finance costs come down, full profitability will remain constrained despite strong operational progress